Lanean...
Targeted therapy of brain metastases: latest evidence and clinical implications
Brain metastases (BM) occur in 20–40% of patients with cancer and 60–75% of patients with BM become symptomatic. Due to an aging population and advances in the treatment of primary cancers, patients are living longer and are more likely to experience complications from BM. The diagnosis of BM drasti...
Gorde:
| Argitaratua izan da: | Ther Adv Med Oncol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
SAGE Publications
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5808839/ https://ncbi.nlm.nih.gov/pubmed/29449898 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834017736252 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|